{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:17:34Z","timestamp":1789179454430,"version":"build-2803163510"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11910-010-0160-0","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T05:47:58Z","timestamp":1289800078000},"page":"67-77","source":"Crossref","is-referenced-by-count":35,"title":["Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010"],"prefix":"10.1007","volume":"11","author":[{"given":"Rebecca","family":"Traub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mitsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis P.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, et al.: Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59\u201362.","journal-title":"Nature"},{"issue":"Suppl 1","key":"160_CR2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009, 65 Suppl 1:S3\u20139.","journal-title":"Ann Neurol"},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/JVI.69.6.3584-3596.1995","volume":"69","author":"SH Ou","year":"1995","unstructured":"Ou SH, Wu F, Harrich D, et al.: Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 1995, 69:3584\u201396.","journal-title":"J Virol"},{"key":"160_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","volume":"7","author":"VM Deerlin Van","year":"2008","unstructured":"Van Deerlin VM, Leverenz JB, Bekris LM, et al.: TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008, 7:409\u201316.","journal-title":"Lancet Neurol"},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, et al.: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006, 351:602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, et al.: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130\u20133.","journal-title":"Science"},{"key":"160_CR7","doi-asserted-by":"crossref","unstructured":"\u2022 Kabashi E, Valdmanis PN, Dion P, et al.: TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008, 40:572-4. This is an early paper that identified the role of TDP-43 mutations in familial and sporadic ALS.","DOI":"10.1038\/ng.132"},{"key":"160_CR8","doi-asserted-by":"crossref","unstructured":"\u2022 Sreedharan J, Blair IP, Tripathi VB, et al.: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668\u201372. This is an early paper that identified the role of TDP-43 mutations in familial and sporadic ALS.","DOI":"10.1126\/science.1154584"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.21392","volume":"63","author":"A Yokoseki","year":"2008","unstructured":"Yokoseki A, Shiga A, Tan CF, et al.: TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008, 63:538\u201342.","journal-title":"Ann Neurol"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.21344","volume":"63","author":"MA Gitcho","year":"2008","unstructured":"Gitcho MA, Baloh RH, Chakraverty S, et al.: TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008, 63:535\u20138.","journal-title":"Ann Neurol"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","volume":"19","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne C, Polymenidou M, Cleveland DW: TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010, 19:R46\u201364.","journal-title":"Hum Mol Genet"},{"key":"160_CR12","unstructured":"Iida A, Kamei T, Sano M, et al.: Large-scale screening of TARDBP mutation in amyotrophic lateral sclerosis in Japanese. Neurobiol Aging 2010."},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2010.04.068","volume":"478","author":"S Sasaki","year":"2010","unstructured":"Sasaki S, Takeda T, Shibata N, Kobayashi M: Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis. Neurosci Lett 2010, 478:72\u20136.","journal-title":"Neurosci Lett"},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/brain\/awq111","volume":"133","author":"AL Nishimura","year":"2010","unstructured":"Nishimura AL, Zupunski V, Troakes C, et al.: Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 2010, 133:1763\u201371.","journal-title":"Brain"},{"key":"160_CR15","doi-asserted-by":"crossref","unstructured":"Wegorzewska I, Bell S, Cairns NJ, et al.: TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 2009,","DOI":"10.1073\/pnas.0908767106"},{"issue":"3","key":"160_CR16","doi-asserted-by":"crossref","first-page":"e1000887","DOI":"10.1371\/journal.pgen.1000887","volume":"6","author":"H Zhou","year":"2010","unstructured":"Zhou H, Huang C, Chen H, et al.: Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 2010 March; 6(3): e1000887.","journal-title":"PLoS Genet."},{"key":"160_CR17","doi-asserted-by":"crossref","unstructured":"Suzuki M, Mikami H, Watanabe T, et al.: Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 2010.","DOI":"10.1111\/j.1600-0404.2010.01321.x"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1242\/jcs.02692","volume":"118","author":"R Fujii","year":"2005","unstructured":"Fujii R, Takumi T: TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci 2005, 118:5755\u201365.","journal-title":"J Cell Sci"},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1074\/jbc.M008304200","volume":"276","author":"A Lerga","year":"2001","unstructured":"Lerga A, Hallier M, Delva L, et al.: Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 2001, 276:6807\u201316.","journal-title":"J Biol Chem"},{"issue":"Pt 15","key":"160_CR20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1242\/jcs.110.15.1741","volume":"110","author":"H Zinszner","year":"1997","unstructured":"Zinszner H, Sok J, Immanuel D, et al.: TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 1997, 110 ( Pt 15):1741\u201350.","journal-title":"J Cell Sci"},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1128\/MCB.19.11.7639","volume":"19","author":"H Ichikawa","year":"1999","unstructured":"Ichikawa H, Shimizu K, Katsu R, Ohki M: Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). Mol Cell Biol 1999, 19:7639\u201350.","journal-title":"Mol Cell Biol"},{"key":"160_CR22","first-page":"3717","volume":"9","author":"DD Prasad","year":"1994","unstructured":"Prasad DD, Ouchida M, Lee L, et al.: TLS\/FUS fusion domain of TLS\/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 1994, 9:3717\u201329.","journal-title":"Oncogene"},{"key":"160_CR23","doi-asserted-by":"crossref","unstructured":"\u2022 Kwiatkowski TJ, Jr., Bosco DA, Leclerc AL, et al.: Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205\u20138. One of the first papers to identify FUS\/TLS mutations in familial ALS.","DOI":"10.1126\/science.1166066"},{"key":"160_CR24","doi-asserted-by":"crossref","unstructured":"\u2022 Vance C, Rogelj B, Hortobagyi T, et al.: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208\u201311. One of the first papers to identify FUS\/TLS mutations in familial ALS.","DOI":"10.1126\/science.1165942"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp.2009.194399","volume":"81","author":"IP Blair","year":"2010","unstructured":"Blair IP, Williams KL, Warraich ST, et al.: FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry 2010, 81:639\u201345.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.neurobiolaging.2009.05.001","volume":"30","author":"A Chio","year":"2009","unstructured":"Chio A, Restagno G, Brunetti M, et al.: Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging 2009, 30:1272\u20135.","journal-title":"Neurobiol Aging"},{"key":"160_CR27","doi-asserted-by":"crossref","unstructured":"\u2022 Corrado L, Del Bo R, Castellotti B, et al.: Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet 2010, 47:190\u20134. This is a particularly notable recent study investigating the occurrence, clinical characteristics, and pathology of FUS\/TLS mutations in familial and sporadic ALS.","DOI":"10.1136\/jmg.2009.071027"},{"key":"160_CR28","unstructured":"Drepper C, Herrmann T, Wessig C, et al.: C-terminal FUS\/TLS mutations in familial and sporadic ALS in Germany. Neurobiol Aging 2009."},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archneurol.2009.329","volume":"67","author":"EJ Groen","year":"2010","unstructured":"Groen EJ, van Es MA, van Vught PW, et al.: FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol 2010, 67:224\u201330.","journal-title":"Arch Neurol"},{"key":"160_CR30","doi-asserted-by":"crossref","unstructured":"\u2022 Hewitt C, Kirby J, Highley JR, et al.: Novel FUS\/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2010, 67:455\u201361. This is a particularly notable recent study investigating the occurrence, clinical characteristics, and pathology of FUS\/TLS mutations in familial and sporadic ALS.","DOI":"10.1001\/archneurol.2010.52"},{"key":"160_CR31","unstructured":"Lai SL, Abramzon Y, Schymick JC, et al.: FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2010."},{"key":"160_CR32","doi-asserted-by":"crossref","unstructured":"Rademakers R, Stewart H, Dejesus-Hernandez M, et al.: Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve 2010.","DOI":"10.1002\/mus.21665"},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1212\/WNL.0b013e3181bbff05","volume":"73","author":"N Ticozzi","year":"2009","unstructured":"Ticozzi N, Silani V, LeClerc AL, et al.: Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 2009, 73:1180\u20135.","journal-title":"Neurology"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1212\/WNL.0b013e3181bbfeef","volume":"73","author":"VV Belzil","year":"2009","unstructured":"Belzil VV, Valdmanis PN, Dion PA, et al.: Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology 2009, 73:1176\u20139.","journal-title":"Neurology"},{"key":"160_CR35","doi-asserted-by":"crossref","unstructured":"Waibel S, Neumann M, Rabe M, et al.: Novel missense and truncating mutations in FUS\/TLS in familial ALS. Neurology 2010.","DOI":"10.1212\/WNL.0b013e3181f07e26"},{"key":"160_CR36","doi-asserted-by":"crossref","unstructured":"Yan J, Deng HX, Siddique N, et al.: Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS\/dementia. Neurology 2010.","DOI":"10.1212\/WNL.0b013e3181f07e0c"},{"key":"160_CR37","doi-asserted-by":"crossref","unstructured":"\u2022 Baumer D, Hilton D, Paine SM, et al.: Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 2010, 75(7):611\u20138. This paper brings a known subtype of juvenile ALS under the spectrum of disease associated with FUS mutations.","DOI":"10.1212\/WNL.0b013e3181ed9cde"},{"key":"160_CR38","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","volume":"75","author":"AL Nishimura","year":"2004","unstructured":"Nishimura AL, Mitne-Neto M, Silva HC, et al.: A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004, 75:822\u201331.","journal-title":"Am J Hum Genet"},{"key":"160_CR39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng1001-166","volume":"29","author":"S Hadano","year":"2001","unstructured":"Hadano S, Hand CK, Osuga H, et al.: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001, 29:166\u201373.","journal-title":"Nat Genet"},{"key":"160_CR40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","volume":"74","author":"YZ Chen","year":"2004","unstructured":"Chen YZ, Bennett CL, Huynh HM, et al.: DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004, 74:1128\u201335.","journal-title":"Am J Hum Genet"},{"key":"160_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajhg.2008.12.010","volume":"84","author":"CY Chow","year":"2009","unstructured":"Chow CY, Landers JE, Bergren SK, et al.: Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 2009, 84:85\u20138.","journal-title":"Am J Hum Genet"},{"key":"160_CR42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","volume":"38","author":"MJ Greenway","year":"2006","unstructured":"Greenway MJ, Andersen PM, Russ C, et al.: ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis. Nat Genet 2006, 38:411\u20133.","journal-title":"Nat Genet"},{"key":"160_CR43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature08971","volume":"465","author":"H Maruyama","year":"2010","unstructured":"Maruyama H, Morino H, Ito H, et al.: Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223\u20136.","journal-title":"Nature"},{"key":"160_CR44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/brain\/awp325","volume":"133","author":"A Orlacchio","year":"2010","unstructured":"Orlacchio A, Babalini C, Borreca A, et al.: SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 2010, 133:591\u20138.","journal-title":"Brain"},{"key":"160_CR45","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.0914128107","volume":"107","author":"J Mitchell","year":"2010","unstructured":"Mitchell J, Paul P, Chen HJ, et al.: Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci U S A 2010, 107:7556\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR46","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000231510.89311.8b","volume":"67","author":"N Parkinson","year":"2006","unstructured":"Parkinson N, Ince PG, Smith MO, et al.: ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006, 67:1074\u20137.","journal-title":"Neurology"},{"key":"160_CR47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ng1609","volume":"37","author":"G Skibinski","year":"2005","unstructured":"Skibinski G, Parkinson NJ, Brown JM, et al.: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005, 37:806\u20138.","journal-title":"Nat Genet"},{"key":"160_CR48","doi-asserted-by":"crossref","first-page":"e9872","DOI":"10.1371\/journal.pone.0009872","volume":"5","author":"LE Cox","year":"2010","unstructured":"Cox LE, Ferraiuolo L, Goodall EF, et al.: Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 2010, 5:e9872.","journal-title":"PLoS One"},{"key":"160_CR49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","volume":"286","author":"MI Mackness","year":"1991","unstructured":"Mackness MI, Arrol S, Durrington PN: Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991, 286:152\u20134.","journal-title":"FEBS Lett"},{"key":"160_CR50","doi-asserted-by":"crossref","unstructured":"\u2022 Ticozzi N, LeClerc AL, Keagle PJ, et al.: Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol 2010, 68:102\u20137. In this study, gene mutations are identified in three paraoxonase (PON) genes in patients with familial and ALS, further strengthening the association of PON with ALS pathogenesis and suggesting a new genetic cause of motor neuron disease.","DOI":"10.1002\/ana.21993"},{"key":"160_CR51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1212\/WNL.0b013e3181aa2a39","volume":"73","author":"DA Greenberg","year":"2009","unstructured":"Greenberg DA, Stewart WC, Rowland LP: Paraoxonase genes and susceptibility to ALS. Neurology 2009, 73:11\u20132.","journal-title":"Neurology"},{"key":"160_CR52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.0b013e3181a18674","volume":"73","author":"AM Wills","year":"2009","unstructured":"Wills AM, Cronin S, Slowik A, et al.: A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 2009, 73:16\u201324.","journal-title":"Neurology"},{"key":"160_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2009.09.029","volume":"288","author":"MJ Strong","year":"2010","unstructured":"Strong MJ: The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J Neurol Sci 2010, 288:1\u201312.","journal-title":"J Neurol Sci"},{"key":"160_CR54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","volume":"432","author":"RI Gregory","year":"2004","unstructured":"Gregory RI, Yan KP, Amuthan G, et al.: The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235\u201340.","journal-title":"Nature"},{"key":"160_CR55","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, Valdez G, Moresi V, et al.: MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549\u201354.","journal-title":"Science"},{"key":"160_CR56","doi-asserted-by":"crossref","unstructured":"Haramati S, Chapnik E, Sztainberg Y, et al.: miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 2010.","DOI":"10.1073\/pnas.1006151107"},{"key":"160_CR57","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","volume":"281","author":"LI Bruijn","year":"1998","unstructured":"Bruijn LI, Houseweart MK, Kato S, et al.: Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281:1851\u20134.","journal-title":"Science"},{"key":"160_CR58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/nbdi.2000.0299","volume":"7","author":"D Jaarsma","year":"2000","unstructured":"Jaarsma D, Haasdijk ED, Grashorn JA, et al.: Human Cu\/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis 2000, 7:623\u201343.","journal-title":"Neurobiol Dis"},{"key":"160_CR59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","volume":"13","author":"AG Reaume","year":"1996","unstructured":"Reaume AG, Elliott JL, Hoffman EK, et al.: Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996, 13:43\u20137.","journal-title":"Nat Genet"},{"key":"160_CR60","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","volume":"22","author":"MM Lino","year":"2002","unstructured":"Lino MM, Schneider C, Caroni P: Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 2002, 22:4825\u201332.","journal-title":"J Neurosci"},{"key":"160_CR61","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","volume":"21","author":"A Pramatarova","year":"2001","unstructured":"Pramatarova A, Laganiere J, Roussel J, et al.: Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 2001, 21:3369\u201374.","journal-title":"J Neurosci"},{"key":"160_CR62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement AM, Nguyen MD, Roberts EA, et al.: Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302:113\u20137.","journal-title":"Science"},{"key":"160_CR63","doi-asserted-by":"crossref","unstructured":"\u2022 Di Giorgio FP, Carrasco MA, Siao MC, et al.: Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007, 10:608\u201314. This paper demonstrates that the neurodegenerative effect of SOD1 mutations are non-neuronal and depend on glial cells.","DOI":"10.1038\/nn1885"},{"key":"160_CR64","doi-asserted-by":"crossref","unstructured":"\u2022 Nagai M, Re DB, Nagata T, et al.: Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007, 10:615\u201322. This paper demonstrates that the neurodegenerative effect of SOD1 mutations are non-neuronal and depend on glial cells.","DOI":"10.1038\/nn1876"},{"key":"160_CR65","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0802556105","volume":"105","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, Boillee S, Roberts EA, et al.: Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A 2008, 105:7594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR66","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1073\/pnas.0813339106","volume":"106","author":"CS Lobsiger","year":"2009","unstructured":"Lobsiger CS, Boillee S, McAlonis-Downes M, et al.: Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci U S A 2009, 106:4465\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0074-7742(02)53015-4","volume":"53","author":"RW Orrell","year":"2002","unstructured":"Orrell RW, Schapira AH: Mitochondria and amyotrophic lateral sclerosis. Int Rev Neurobiol 2002, 53:411\u201326.","journal-title":"Int Rev Neurobiol"},{"key":"160_CR68","doi-asserted-by":"crossref","unstructured":"Huang EJ, Zhang J, Geser F, et al.: Extensive FUS-Immunoreactive Pathology in Juvenile Amyotrophic Lateral Sclerosis with Basophilic Inclusions. Brain Pathol 2010.","DOI":"10.1111\/j.1750-3639.2010.00413.x"},{"key":"160_CR69","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.M109.041319","volume":"285","author":"J Zhou","year":"2010","unstructured":"Zhou J, Yi J, Fu R, et al.: Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem 2010, 285:705\u201312.","journal-title":"J Biol Chem"},{"key":"160_CR70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tins.2010.03.006","volume":"33","author":"E Perlson","year":"2010","unstructured":"Perlson E, Maday S, Fu MM, et al.: Retrograde axonal transport: pathways to cell death? Trends Neurosci 2010, 33:335\u201344.","journal-title":"Trends Neurosci"},{"key":"160_CR71","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/hmg\/ddq202","volume":"19","author":"S Pedrini","year":"2010","unstructured":"Pedrini S, Sau D, Guareschi S, et al.: ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet 2010, 19:2974\u201386.","journal-title":"Hum Mol Genet"},{"key":"160_CR72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00429-009-0226-4","volume":"214","author":"K Chen","year":"2010","unstructured":"Chen K, Northington FJ, Martin LJ: Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct Funct 2010, 214:219\u201334.","journal-title":"Brain Struct Funct"},{"key":"160_CR73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2009.02.015","volume":"218","author":"LJ Martin","year":"2009","unstructured":"Martin LJ, Gertz B, Pan Y, et al.: The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol 2009, 218:333\u201346.","journal-title":"Exp Neurol"},{"key":"160_CR74","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneurol.2010.128","volume":"67","author":"V Crugnola","year":"2010","unstructured":"Crugnola V, Lamperti C, Lucchini V, et al.: Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol 2010, 67:849\u201354.","journal-title":"Arch Neurol"},{"key":"160_CR75","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archneurol.2007.65","volume":"65","author":"M Hirano","year":"2008","unstructured":"Hirano M, Angelini C, Montagna P, et al.: Amyotrophic lateral sclerosis with ragged-red fibers. Arch Neurol 2008, 65:403\u20136.","journal-title":"Arch Neurol"},{"key":"160_CR76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V: A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group. N Engl J Med 1994, 330:585\u201391.","journal-title":"N Engl J Med"},{"key":"160_CR77","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1212\/WNL.47.6_Suppl_4.242S","volume":"47","author":"L Lacomblez","year":"1996","unstructured":"Lacomblez L, Bensimon G, Leigh PN, et al.: A confirmatory dose-ranging study of riluzole in ALS. ALS\/Riluzole Study Group-II. Neurology 1996, 47:S242\u201350.","journal-title":"Neurology"},{"key":"160_CR78","doi-asserted-by":"crossref","unstructured":"Miller RG, Mitchell JD, Lyon M, Moore DH: Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst Rev 2007:CD001447.","DOI":"10.1002\/14651858.CD001447.pub2"},{"key":"160_CR79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(10)70068-5","volume":"9","author":"SP Aggarwal","year":"2010","unstructured":"Aggarwal SP, Zinman L, Simpson E, et al.: Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010, 9:481\u20138.","journal-title":"Lancet Neurol"},{"key":"160_CR80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.21620","volume":"66","author":"S Piepers","year":"2009","unstructured":"Piepers S, Veldink JH, de Jong SW, et al.: Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Ann Neurol 2009, 66:227\u201334.","journal-title":"Ann Neurol"},{"key":"160_CR81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","volume":"66","author":"P Kaufmann","year":"2009","unstructured":"Kaufmann P, Thompson JL, Levy G, et al.: Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 2009, 66:235\u201344.","journal-title":"Ann Neurol"},{"key":"160_CR82","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature02872","volume":"431","author":"CC Mello","year":"2004","unstructured":"Mello CC, Conte D, Jr.: Revealing the world of RNA interference. Nature 2004, 431:338\u201342.","journal-title":"Nature"},{"key":"160_CR83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph GS, Radcliffe PA, Day DM, et al.: Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 2005, 11:429\u201333.","journal-title":"Nat Med"},{"key":"160_CR84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","volume":"11","author":"C Raoul","year":"2005","unstructured":"Raoul C, Abbas-Terki T, Bensadoun JC, et al.: Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005, 11:423\u20138.","journal-title":"Nat Med"},{"key":"160_CR85","doi-asserted-by":"crossref","first-page":"42826","DOI":"10.1074\/jbc.M507685200","volume":"280","author":"Y Saito","year":"2005","unstructured":"Saito Y, Yokota T, Mitani T, et al.: Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model. J Biol Chem 2005, 280:42826\u201330.","journal-title":"J Biol Chem"},{"key":"160_CR86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.21152","volume":"62","author":"F Locatelli","year":"2007","unstructured":"Locatelli F, Corti S, Papadimitriou D, et al.: Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice. Ann Neurol 2007, 62:81\u201392.","journal-title":"Ann Neurol"},{"key":"160_CR87","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20453","volume":"57","author":"TM Miller","year":"2005","unstructured":"Miller TM, Kaspar BK, Kops GJ, et al.: Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol 2005, 57:773\u20136.","journal-title":"Ann Neurol"},{"key":"160_CR88","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2008.73","volume":"16","author":"C Towne","year":"2008","unstructured":"Towne C, Raoul C, Schneider BL, Aebischer P: Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol Ther 2008, 16:1018\u201325.","journal-title":"Mol Ther"},{"key":"160_CR89","doi-asserted-by":"crossref","first-page":"15845","DOI":"10.1074\/jbc.M800834200","volume":"283","author":"H Wang","year":"2008","unstructured":"Wang H, Ghosh A, Baigude H, et al.: Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression. J Biol Chem 2008, 283:15845\u201352.","journal-title":"J Biol Chem"},{"key":"160_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00221-009-1742-4","volume":"195","author":"AA Rizvanov","year":"2009","unstructured":"Rizvanov AA, Mukhamedyarov MA, Palotas A, Islamov RR: Retrogradely transported siRNA silences human mutant SOD1 in spinal cord motor neurons. Exp Brain Res 2009, 195:1\u20134.","journal-title":"Exp Brain Res"},{"key":"160_CR91","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1089\/ars.2009.2618","volume":"11","author":"R Wu","year":"2009","unstructured":"Wu R, Wang H, Xia X, et al.: Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS. Antioxid Redox Signal 2009, 11:1523\u201334.","journal-title":"Antioxid Redox Signal"},{"key":"160_CR92","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneurol.2009.180","volume":"66","author":"SQ Harper","year":"2009","unstructured":"Harper SQ: Progress and challenges in RNA interference therapy for Huntington disease. Arch Neurol 2009, 66:933\u20138.","journal-title":"Arch Neurol"},{"key":"160_CR93","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","volume":"31","author":"A Vercelli","year":"2008","unstructured":"Vercelli A, Mereuta OM, Garbossa D, et al.: Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008, 31:395\u2013405.","journal-title":"Neurobiol Dis"},{"key":"160_CR94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2007.05.016","volume":"265","author":"L Mazzini","year":"2008","unstructured":"Mazzini L, Mareschi K, Ferrero I, et al.: Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci 2008, 265:78\u201383.","journal-title":"J Neurol Sci"},{"key":"160_CR95","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2009.10.074","volume":"468","author":"H Kim","year":"2010","unstructured":"Kim H, Kim HY, Choi MR, et al.: Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett 2010, 468:190\u20134.","journal-title":"Neurosci Lett"},{"key":"160_CR96","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/jnr.22038","volume":"87","author":"C Boucherie","year":"2009","unstructured":"Boucherie C, Schafer S, Lavand\u2019homme P, et al.: Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res 2009, 87:2034\u201346.","journal-title":"J Neurosci Res"},{"key":"160_CR97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","volume":"223","author":"L Mazzini","year":"2010","unstructured":"Mazzini L, Ferrero I, Luparello V, et al.: Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol 2010, 223:229\u201337.","journal-title":"Exp Neurol"},{"key":"160_CR98","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/14653240802549470","volume":"11","author":"H Deda","year":"2009","unstructured":"Deda H, Inci MC, Kurekci AE, et al.: Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009, 11:18\u201325.","journal-title":"Cytotherapy"},{"key":"160_CR99","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1073\/pnas.0607423103","volume":"103","author":"DR Beers","year":"2006","unstructured":"Beers DR, Henkel JS, Xiao Q, et al.: Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2006, 103:16021\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR100","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh273","volume":"127","author":"S Corti","year":"2004","unstructured":"Corti S, Locatelli F, Donadoni C, et al.: Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004, 127:2518\u201332.","journal-title":"Brain"},{"key":"160_CR101","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2009.08.012","volume":"1296","author":"S Ohnishi","year":"2009","unstructured":"Ohnishi S, Ito H, Suzuki Y, et al.: Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis. Brain Res 2009, 1296:216\u201324.","journal-title":"Brain Res"},{"issue":"19","key":"160_CR102","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1093\/hmg\/ddq293","volume":"19","author":"S Corti","year":"2010","unstructured":"Corti S, Nizzardo M, Nardini M, et al.: Systemic transplantation of c-kit + cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum Mol Genet 2010, 19(19):3782\u201396.","journal-title":"Hum Mol Genet"},{"key":"160_CR103","doi-asserted-by":"crossref","unstructured":"\u2022 Appel SH, Engelhardt JI, Henkel JS, et al.: Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008, 71:1326\u201334. This study showed that hematopoietic stem cells can engraft in the human CNS, but that in this small study there was no clinical benefit.","DOI":"10.1212\/01.wnl.0000327668.43541.22"},{"key":"160_CR104","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/brain\/awm043","volume":"130","author":"S Corti","year":"2007","unstructured":"Corti S, Locatelli F, Papadimitriou D, et al.: Neural stem cells LewisX + CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 2007, 130:1289\u2013305.","journal-title":"Brain"},{"key":"160_CR105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","volume":"82","author":"L Xu","year":"2006","unstructured":"Xu L, Yan J, Chen D, et al.: Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006, 82:865\u201375.","journal-title":"Transplantation"},{"key":"160_CR106","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cne.22022","volume":"514","author":"L Xu","year":"2009","unstructured":"Xu L, Ryugo DK, Pongstaporn T, et al.: Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. J Comp Neurol 2009, 514:297\u2013309.","journal-title":"J Comp Neurol"},{"key":"160_CR107","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1073\/pnas.0711983105","volume":"105","author":"WE Lowry","year":"2008","unstructured":"Lowry WE, Richter L, Yachechko R, et al.: Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008, 105:2883\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR108","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA, et al.: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141\u20136.","journal-title":"Nature"},{"key":"160_CR109","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861\u201372.","journal-title":"Cell"},{"key":"160_CR110","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917\u201320.","journal-title":"Science"},{"key":"160_CR111","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1634\/stemcells.2007-0097","volume":"25","author":"H Lee","year":"2007","unstructured":"Lee H, Shamy GA, Elkabetz Y, et al.: Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25:1931\u20139.","journal-title":"Stem Cells"},{"key":"160_CR112","doi-asserted-by":"crossref","unstructured":"\u2022 Dimos JT, Rodolfa KT, Niakan KK, et al.: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218\u201321. In this study, iPSCs were generated from a patient with ALS and were directed to differentiate into motor neurons. This is an early use of iPSCs in ALS.","DOI":"10.1126\/science.1158799"},{"key":"160_CR113","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD, Yu J, Rose FF, Jr., et al.: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277\u201380.","journal-title":"Nature"},{"key":"160_CR114","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/stem.31","volume":"27","author":"S Karumbayaram","year":"2009","unstructured":"Karumbayaram S, Novitch BG, Patterson M, et al.: Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27:806\u201311.","journal-title":"Stem Cells"},{"key":"160_CR115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","volume":"120","author":"MA Passini","year":"2010","unstructured":"Passini MA, Bu J, Roskelley EM, et al.: CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J Clin Invest 2010, 120:1253\u201364.","journal-title":"J Clin Invest"},{"key":"160_CR116","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1073\/pnas.0606201104","volume":"104","author":"M Urushitani","year":"2007","unstructured":"Urushitani M, Ezzi SA, Julien JP: Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2007, 104:2495\u2013500.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR117","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2010.06683.x","volume":"113","author":"F Gros-Louis","year":"2010","unstructured":"Gros-Louis F, Soucy G, Lariviere R, Julien JP: Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem 2010, 113:1188\u201399.","journal-title":"J Neurochem"},{"key":"160_CR118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","volume":"61","author":"JM Orgogozo","year":"2003","unstructured":"Orgogozo JM, Gilman S, Dartigues JF, et al.: Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003, 61:46\u201354.","journal-title":"Neurology"},{"key":"160_CR119","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/17482960903307805","volume":"11","author":"RM Pascuzzi","year":"2010","unstructured":"Pascuzzi RM, Shefner J, Chappell AS, et al.: A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010, 11:266\u201371.","journal-title":"Amyotroph Lateral Scler"},{"key":"160_CR120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/17482960902933809","volume":"11","author":"B Nefussy","year":"2010","unstructured":"Nefussy B, Artamonov I, Deutsch V, et al.: Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study. Amyotroph Lateral Scler 2010, 11:187\u201393.","journal-title":"Amyotroph Lateral Scler"},{"key":"160_CR121","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/17482960802588059","volume":"10","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Wang L, Fu Y, et al.: Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009, 10:430\u20131.","journal-title":"Amyotroph Lateral Scler"},{"key":"160_CR122","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","volume":"63","author":"BR Brooks","year":"2004","unstructured":"Brooks BR, Thisted RA, Appel SH, et al.: Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial. Neurology 2004, 63:1364\u201370.","journal-title":"Neurology"},{"key":"160_CR123","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21245","volume":"39","author":"JG Rabkin","year":"2009","unstructured":"Rabkin JG, Gordon PH, McElhiney M, et al.: Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve 2009, 39:297\u2013303.","journal-title":"Muscle Nerve"},{"key":"160_CR124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/17482960903264998","volume":"11","author":"F Gilio","year":"2010","unstructured":"Gilio F, Iacovelli E, Frasca V, et al.: Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study. Amyotroph Lateral Scler 2010, 11:359\u201363.","journal-title":"Amyotroph Lateral Scler"},{"key":"160_CR125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits JM, La Spada AR: ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009, 73:805\u201311.","journal-title":"Neurology"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-010-0160-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0160-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T06:56:07Z","timestamp":1711954567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-010-0160-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s11910-010-0160-0","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]}}}